Nevertheless, the prognostic significance of YKL-40 in breast cancer patients remains undetermined due to the discrepant reports by studies focusing on the association between YKL-40 expression and survival of patients with breast cancer, which may be partially attributed to varying sample sizes, ethnicities and evaluation methods of YKL-40 expression in individual studies. The gene discussed is CHI3L1; the disease is breast cancer.